Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes
Primary Purpose
Type 2 Diabetes
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cocoa polyphenols
Sponsored by

About this trial
This is an interventional prevention trial for Type 2 Diabetes focused on measuring diabetes, cocoa polyphenols, postprandial glycemia, postprandial lipemia
Eligibility Criteria
Inclusion Criteria:
- clinical diagnosis of type 2diabetes
Exclusion Criteria:
- on insulin therapy
Sites / Locations
- Department of Nutritional Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Cocoa
Placebo
Arm Description
Cocoa polyphenols (960mg)
Placebo powder (109mg polyphenols) in water
Outcomes
Primary Outcome Measures
Blood pressure (mm Hg)
Change in blood pressure and vascular function following cocoa and placebo intervention
Secondary Outcome Measures
Glucose (mg/dL)
Change in glucose levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa and placebo intervention
Blood lipids
Change in lipids and lipoprotein levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa
Inflammation
Change in CRP and interleukins levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01886989
Brief Title
Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes
Official Title
Postprandial Effects of Polyphenol-rich Cocoa Beverage on Glucose, Insulin, Lipids, Oxidative Stress and Inflammation in Type 2 Diabetic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Arpita Basu
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study aims to investigate the postprandial effects of cocoa supplementation in glucose and lipids, and surrogate markers of atherosclerosis in patients with type 2 diabetes. The investigators aim to test the hypothesis that cocoa will lower high-fat mixed meal breakfast-induced postprandial rise of glucose, lipids and markers of atherosclerosis in patients with diabetes. Randomized cross-over controlled trial, in which participants will be assigned to the placebo or cocoa group with breakfast meal. Patients with type 2 diabetes(n=25) will qualify for the study. The participants will be asked to consume 2 cups cocoa or placebo beverage on 2 separate postprandial study days. Both groups will receive high-fat mixed meal breakfast on each day. Blood draws and blood pressure (including HDI) measurements will be conducted at fasting, 30 min, 1,2, 4 & 6 hours postprandial each day for 2 days.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
diabetes, cocoa polyphenols, postprandial glycemia, postprandial lipemia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
18 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cocoa
Arm Type
Experimental
Arm Description
Cocoa polyphenols (960mg)
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo powder (109mg polyphenols) in water
Intervention Type
Dietary Supplement
Intervention Name(s)
Cocoa polyphenols
Intervention Description
Cocoa polyphenols (960mg) reconstituted in water
Primary Outcome Measure Information:
Title
Blood pressure (mm Hg)
Description
Change in blood pressure and vascular function following cocoa and placebo intervention
Time Frame
2.5 years
Secondary Outcome Measure Information:
Title
Glucose (mg/dL)
Description
Change in glucose levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa and placebo intervention
Time Frame
2.5 years
Title
Blood lipids
Description
Change in lipids and lipoprotein levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa
Time Frame
2.5 years
Title
Inflammation
Description
Change in CRP and interleukins levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa
Time Frame
2.5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
clinical diagnosis of type 2diabetes
Exclusion Criteria:
on insulin therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
ARPITA BASU, PHD
Organizational Affiliation
Oklahoma State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Nutritional Sciences
City
Stillwater
State/Province
Oklahoma
ZIP/Postal Code
74078
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
32605005
Citation
Davis DW, Tallent R, Navalta JW, Salazar A, Lyons TJ, Basu A. Effects of Acute Cocoa Supplementation on Postprandial Apolipoproteins, Lipoprotein Subclasses, and Inflammatory Biomarkers in Adults with Type 2 Diabetes after a High-Fat Meal. Nutrients. 2020 Jun 27;12(7):1902. doi: 10.3390/nu12071902.
Results Reference
derived
PubMed Identifier
26338890
Citation
Basu A, Betts NM, Leyva MJ, Fu D, Aston CE, Lyons TJ. Acute Cocoa Supplementation Increases Postprandial HDL Cholesterol and Insulin in Obese Adults with Type 2 Diabetes after Consumption of a High-Fat Breakfast. J Nutr. 2015 Oct;145(10):2325-32. doi: 10.3945/jn.115.215772. Epub 2015 Sep 2.
Results Reference
derived
Learn more about this trial
Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes
We'll reach out to this number within 24 hrs